GARDskin approved by OECD
THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay
The GARD® technology: An holistic approach
SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.
Press Releases
14 Dec, 2017
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
10 Oct, 2017
News
IR
English
Corporate Information
Other Corporate Information
08 Sep, 2017
News
IR
English
Corporate Information
Other Corporate Information